Onconic Therapeutics Inc.

Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.

476060 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 강남구 테헤란로26길 12 제일비젼타워 11층, 강남구
Website:: http://onconic.co.kr/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Onconic Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of innovative drugs for cancer and gastrointestinal diseases. A subsidiary of Jeil Pharmaceutical, the company focuses on therapeutic areas with high unmet medical needs and significant market potential. Its development pipeline features novel treatments for acid-related conditions, including ZacuCorrection (zastaprazan), a next-generation potassium-competitive acid blocker (P-CAB) designed to treat gastroesophageal reflux disease. Onconic Therapeutics aims to advance its portfolio through clinical development and strategic collaborations to bring new therapeutic options to patients.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Onconic Therapeutics Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Onconic Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Onconic Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
APURES CO., LTD. Biotech R&D using a miniature pig model, offering CRO services and biomaterials to pharma.	South Korea	149300
Arterra Bioscience Develops natural active ingredients via biotechnology for cosmetic, pharma, and food sectors.	Italy	ABS
ASUA Inc. Consulting and solutions provider enhancing logistics safety and efficiency with IoT and telecom.	Japan	246A
Atomera Inc. Licenses patented material IP (MST®) to create higher-performance, lower-power semiconductors.	United States of America	ATOM
Atrae, Inc. Develops People Tech solutions for HR, including big data job sites and organizational analytics.	Japan	6194
Aura Energy Limited Developing uranium and battery minerals for the nuclear energy and energy storage markets.	Australia	N/A
BayCurrent, Inc. Comprehensive consulting on strategy, AI, and digital transformation for corporations and government.	Japan	6532
BenevolentAI An AI-powered drug discovery platform accelerating R&D for scientists and pharmaceutical partners.	United Kingdom	BAI
BerGenBio Develops first-in-class AXL kinase inhibitors for cancer and severe respiratory infections.	Norway	BGBIO
Bergman & Beving Acquires and develops niche companies with solutions for the industrial and construction sectors.	Sweden	BERG